The US President's Emergency Plan to Reduce AIDS (PEPFAR) announced on Monday, April 8, that there is an increasing number of new HIV infections in the Democratic Republic of the Congo.
This came during her presentation to the press in Kinshasa of the results of the activities of American organizations and agencies that support the health sector and their effects in the Democratic Republic of the Congo.
According to PEPFAR's Medical Director, Dr. Olivier Kalombo, about two hundred thousand patients have lifelong access to antiretrovirals in the Democratic Republic of the Congo.
Dr. Kalombo also emphasizes that these major advances in the fight against HIV have been achieved thanks to the mobilization of a budget of one hundred billion dollars over 24 years of activities.
For the Director of the National Multisectoral AIDS Programme, Dr. Emi Mboyo, the American contribution to the health sector in the Democratic Republic of the Congo is beneficial, not only to the ministry but especially to the Congolese population.
Vaccine against monkeypox
DRC Director of the Centers for Disease Control and Prevention (CDC), Dr. Joel Kabamba, noted during this exchange with the media that a vaccine is currently being tested to contain monkeypox, or monkeypox.
She added that this significant result was possible thanks to the work her agency is doing alongside the Congolese government.
The United States Agency for International Development (USAID), for its part, revealed that it provides a budget estimated at approximately two hundred and forty million dollars annually for the health sector, i.e. more than seventy percent of its entire budget.
The family planning director and supporter of the USAID's reproduction of a country with more and more travailer access to local organizations and new programs for the RDC government ax on the maternité and medical supplies. the basic.
:quality(70):focal(1515x1438:1525x1448)/cloudfront-eu-central-1.images.arcpublishing.com/liberation/X7T4FCTMWVF2NACF35CCUHUPTE.jpg)
